RA
ASTH icon

Royce & Associates’s Astrana Health ASTH Stock Holding History

Royce & Associates’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.9M Buy
472,480
+75,519
+19% +$2.72M 0.18% 192
2026
Q1 		$9.73M Buy
396,961
+48,630
+14% +$1.15M 0.1% 335
2025
Q4 		$8.64M Buy
348,331
+88,978
+34% +$2.36M 0.09% 350
2025
Q3 		$7.35M Sell
259,353
-48,135
-16% -$1.3M 0.07% 386
2025
Q2 		$7.65M Buy
307,488
+16,781
+6% +$473K 0.08% 366
2025
Q1 		$9.01M Buy
290,707
+35,155
+14% +$1.17M 0.1% 310
2024
Q4 		$8.06M Buy
255,552
+140,584
+122% +$6.68M 0.07% 380
2024
Q3 		$6.66M Buy
114,968
+100,000
+668% +$4.91M 0.06% 420
2024
Q2 		$607K Hold
14,968
– – 0.01% 775
2024
Q1 		$629K Buy
+14,968
New +$584K 0.01% 770
2019
Q2 		– Sell
-22,859
Closed -$419K – 1199
2019
Q1 		$419K Sell
22,859
-42,125
-65% -$808K ﹤0.01% 933
2018
Q4 		$1.29M Sell
64,984
-21,000
-24% -$393K 0.01% 822
2018
Q3 		$1.9M Buy
+85,984
New +$1.81M 0.01% 838
2018
Q2 		– Sell
-208
Closed -$3K – 1261
2018
Q1 		$3K Buy
+208
New +$4.31K ﹤0.01% 1251

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Royce & Associates's ASTH Position: Q2 2026 in Review

Royce & Associates increased its Astrana Health (ASTH) stake by 19% in Q2 2026, buying an estimated $2.72M and bringing the position to 472,480 shares worth $21.9M. The position accounts for 0.18% of the portfolio, ranked #192.

Royce & Associates first reported a position in ASTH in Q1 2018 and has held it in 14 quarters since. 209 funds tracked by Wall St. Rank hold ASTH as of Q2 2026.

  • Royce & Associates held 472,480 shares of Astrana Health worth $21.9M as of Q2 2026.
  • Royce & Associates bought 75,519 Astrana Health shares in Q2 2026, an estimated $2.72M.
  • Astrana Health made up 0.18% of Royce & Associates's portfolio in Q2 2026, its #192 holding.
  • Royce & Associates first reported a position in Astrana Health in Q1 2018 and has held it in 14 quarters since.
  • 209 funds tracked by Wall St. Rank held Astrana Health as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.